Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APC8020 Vaccine with Cytokines in Multiple Myeloma
NCT00616720Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2001
- Primary completion
- Nov 2007
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 2 trial of APC8020 in multiple myeloma (MM), sponsored by Mayo Clinic. Started Aug 2001; status: completed.
02
Drugs
APC8020
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00616720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616720.